Second Sight Medical (EYES) Momentum Continues Following Robust IPO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Second Sight Medical (EYES) Sees Profit Taking after 162% Post-IPO Surge
November 21, 2014 10:25 AM ESTThis week's hot IPO for Second Sight Medical (NASDAQ: EYES) is giving some back today. After gaining 162% in it fist two days of trading, shares are down 9.5% to $21.35 today. The IPO priced at $9.
Second Sight develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients
... MoreMarket Wrap: Housing Starts Lag in Oct.; Fed to Keep on Path Amid Global Concerns; Target Surprises in Q3
November 19, 2014 5:25 PM ESTMarket wrap for November 19th
End of the Day: S&P 500 down 3.1 to 2,048.72; Dow Jones down 2.1 to 17,685.73; Nasdaq down 26.7 to 4,675.71
* Privately-owned housing starts in October were at a seasonally adjusted annual rate of 1.009 million. (Consensus estimates were at 1.025 million.) This is 2.8 percent (±10.0%)* below the revised September estimate of 1.038 million, but is 7.8 percent (±8.7%)* above the October 2013 rate of 936,000. Privately-owned housing units authorized by building permits in October were at a seasonally adjusted annual rate of 1.08 million. This is 4.8 percent (±1.3%) above the revised September rate of 1.031 million and is 1.2 percent... More
Second Sight Medical (EYES) Picks Up Chatter Ahead of CNBC Coverage
November 19, 2014 12:50 PM ESTWhile off the highs, traders are getting chatty about today's IPO for Second Sight Medical Products (NASDAQ: EYES) as it is expected to be highlighted on CNBC in a little while. Shares are up 105% at last check to $18.50 after pricing at $9.
... MoreSecond Sight Medical (EYES) IPO Immediately Halted on Opening Surge
November 19, 2014 12:09 PM ESTToday's IPO for Second Sight Medical (NASDAQ: EYES) was immediately halted upon opening for trading at $17 versus the IPO price of $9.
... MoreSecond Sight Medical (EYES) IPO Opens Sharply Higher
November 19, 2014 12:06 PM ESTToday's IPO for Second Sight Medical (NASDAQ: EYES) opened for trading at $17 after pricing 3,500,000 shares of common stock at a price of $9.00 per share, in-line with the expected pricing.
MDB Capital Group, LLC served as the sole underwriter in connection with the... More



